Klausner J M, Paterson I S, Valeri C R, Shepro D, Hechtman H B
Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115.
Ann Surg. 1988 Dec;208(6):755-60. doi: 10.1097/00000658-198812000-00014.
This study tests the role of white blood cells (WBC) and leukotrienes in mediating the increased microvascular permeability following ischemia and reperfusion. Anesthetized dogs (n = 23) underwent 2 hours of hind limb ischemia induced by tourniquet inflation to 300 mmHg. In untreated animals (n = 7), tourniquet release led after 5 minutes to a rise in plasma thromboxane (Tx) B2 levels from 360 to 1702 pg/ml (p less than 0.05); after 2 hours, lymph TxB2 concentration had risen from 412 to 1598 pg/ml (p less than 0.05). There were decreases in circulating WBC from 11,766 to 6550/mm3 and platelets from 230 to 155 x 10(3)/mm3. During reperfusion, popliteal lymph flow (QL) increased from 0.07 to 0.24 ml/hour (p less than 0.05), while the lymph/plasma (L/P) protein ratio was unchanged from 0.39, changes consistent with increased microvascular permeability. WBC depletion (n = 7) to 302/mm3 by hydroxyurea or nitrogen mustard attentuated (p less than 0.05) the reperfusion induced rise in plasma TxB2 from 91 to 248 pg/ml and prevented the increase in lymph TxB2 concentration. Within 5 minutes of tourniquet release WBC counts further decreased to 191/mm3 (p less than 0.05) and platelets declined from 175 to 93 x 10(3)/mm3 (p less than 0.05). QL increased from 0.07 to 0.12 ml/hour (p less than 0.05), lower than untreated animals (p less than 0.05), and the L/P protein ratio declined from 0.49 to 0.37 (p less than 0.05), dilutional changes consistent with increased filtration pressure but not permeability to protein. Pretreatment with the lipoxygenase inhibitor diethylcarbamazine (DEC) (n = 8) prevented the reperfusion-induced increase in plasma and lymph TxB2 levels (p less than 0.05) and the fall in WBC counts (p less than 0.05), while platelet counts declined from 381 to 210 x 10(3)/mm3 (p less than 0.05). QL rose from 0.09 to 0.23 ml/hour (p less than 0.05) during reperfusion, and the L/P protein ratio of 0.3 remained unchanged, a value lower than in untreated dogs (p less than 0.05). In two animals of each group, vascular recruitment was induced by tourniquet inflation to 50 mmHg. This led to a high QL of 0.25 ml/hour and a low L/P ratio of 0.18. In untreated animals during reperfusion, QL further increased to 1.3 ml/hour, and L/P ratio rose to 0.44, documenting increased vascular permeability. In contrast, reperfusion in leukopenic or diethylcarbamazine (DEC)-treated dogs with vascular recruitment, was not associated with increases in QL or the L/P protein ratio.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究测试了白细胞(WBC)和白三烯在介导缺血再灌注后微血管通透性增加中的作用。对23只麻醉犬进行实验,通过将止血带充气至300 mmHg诱导后肢缺血2小时。在未治疗的动物(n = 7)中,松开止血带5分钟后,血浆血栓素(Tx)B2水平从360 pg/ml升至1702 pg/ml(p < 0.05);2小时后,淋巴TxB2浓度从412 pg/ml升至1598 pg/ml(p < 0.05)。循环白细胞从11,766/mm³降至6550/mm³,血小板从230×10³/mm³降至155×10³/mm³。再灌注期间,腘淋巴流量(QL)从0.07 ml/小时增加至0.24 ml/小时(p < 0.05),而淋巴/血浆(L/P)蛋白比值从0.39未变,这些变化与微血管通透性增加一致。通过羟基脲或氮芥将白细胞减少至302/mm³(n = 7)可减弱(p < 0.05)再灌注诱导的血浆TxB2从91 pg/ml升至248 pg/ml,并防止淋巴TxB2浓度升高。松开止血带5分钟内,白细胞计数进一步降至191/mm³(p < 0.05),血小板从175×10³/mm³降至93×10³/mm³(p < 0.05)。QL从0.07 ml/小时增加至0.12 ml/小时(p < 0.05),低于未治疗动物(p < 0.05),L/P蛋白比值从0.49降至0.37(p < 0.05),稀释变化与滤过压增加一致,但与蛋白通透性无关。用脂氧合酶抑制剂二乙氨基甲嗪(DEC)预处理(n = 8)可防止再灌注诱导的血浆和淋巴TxB2水平升高(p < 0.05)以及白细胞计数下降(p < 0.05),而血小板计数从381×10³/mm³降至210×10³/mm³(p < 0.05)。再灌注期间QL从0.09 ml/小时升至0.23 ml/小时(p < 0.05),L/P蛋白比值0.3保持不变,该值低于未治疗犬(p < 0.05)。每组两只动物中,通过将止血带充气至50 mmHg诱导血管募集。这导致高QL为0.25 ml/小时和低L/P比值为0.18。在未治疗动物再灌注期间,QL进一步增加至1.3 ml/小时,L/P比值升至0.44,证明血管通透性增加。相比之下,白细胞减少或经二乙氨基甲嗪(DEC)治疗的犬在血管募集后再灌注,与QL或L/P蛋白比值增加无关。(摘要截短于400字)